लोड हो रहा है...
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma
Temsirolimus is an inhibitor of the mammalian target of rapamycin (mTOR) kinase, a protein that has been shown to be particularly active in metastatic renal cell carcinoma (mRCC) with poor prognosis. Therefore, temsirolimus should be considered as the first-line treatment indicated in mRCC patients...
में बचाया:
| में प्रकाशित: | Ther Adv Urol |
|---|---|
| मुख्य लेखकों: | , , , , , , , |
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publications
2015
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4485412/ https://ncbi.nlm.nih.gov/pubmed/26161146 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215574457 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|